TARGETING HIF-1 PATHWAY: A THERAPEUTIC APPROACH TO KILL CANCER CELLS
Journal: Indo American Journal of Pharmaceutical Sciences (IAJPS) (Vol.04, No. 11)Publication Date: 2017-11-01
Authors : Ajaz Ahmad Waza Shabir Ahmad Bhat Zeenat Hamid;
Page : 4088-4093
Keywords : HIF-1 Pathway; Cancer; Hypoxia-Inducible;
Abstract
Tumorous growth often faces hypoxic (low oxygen tension) conditions and the adaptations of these cells to hypoxic conditions determine their survival. The cancer cells respond to hypoxia by altering the expression of different genes and Hypoxia-Inducible Factor (HIF)-1 is one of it. HIF-1 is a transcriptional factor that response to hypoxia (low oxygen tension) conditions quickly. Expression of HIF-1 gene is essential for increase in vascularization of hypoxic region such as tumor and thus aid in proliferation and survival of cancerous cells. Moreover, HIF-1 signaling in cancer cells has a diverse influence on the metastatic cascade. Targeting HIF-1 is therefore one of the most promising approach to treat cancer. In this review, we have focused on the potential of targeting HIF-1 pathway as therapeutic intervention to treat cancer. Key words: HIF-1 Pathway, Cancer, Hypoxia-Inducible
Other Latest Articles
- TOXIC METAL DETECTION IN NATURAL/HERBAL PRODUCTS IN THE MARKET OF QUETTA, PAKISTAN
- NATURAL INDICATORS AS ALTERNATIVE TO SYNTHETIC ACID BASE INDICATORS
- FORMULATION AND EVALUATION OF CLINDAMYCIN PHOSPHATE EMULGEL
- MAGMATIC EVALUATION OF THE KOH E SULTAN VOLCANO CHAGAI DISTRIC, BALOCHISTAN, PAKISTAN
- A REVIEW ON DESMOGLEINS, DESMOCOLLINS AND ASSOCIATED DISEASES
Last modified: 2017-11-14 17:23:38